The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its closed-loop ... The company’s Evoke spinal cord stimulator, approved by ...

The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...

EVATM Approved for Use with the Evoke® Smart Loop System in the U.S. Potential to Improve Outcomes and Reduce Burden ...

automated patient programming platform in spinal cord stimulation (SCS), representing a significant advancement for SCS therapy. The new programming platform, EVA™, is compatible with all ...

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...

Implantable devices have been approved by the US Food and Drug Administration for movement disorders such as Parkinson's disease (via deep brain stimulation); back pain and injury-related motor ...

Spinal cord stimulation can be an effective treatment for managing ... In addition, their FDA-approved closed-loop Inceptiv SCS system addresses the variability in patient experience by sensing neural ...